Unlock your academic potential and expand your network by joining us!

Dr. Khashayar Dashtipour

MD, PhD; Department of Neurology, School of Medicine, Loma Linda University, 113...

Share Link

Share

Information

Dr. Khashayar Dashtipour is an Associate Professor of Neurology and Basic Sciences and Director of the Division of Movement Disorders at Loma Linda University. He received his medical degree from Ahvaz Jundishapur University of Medical Sciences and has been in practice for more than 20 years. Dr. Dashtipour has been the principal investigator or sub-investigator of over 40 clinical trials. He is an active member of the Parkinson Study Group, The American Academy of Neurology, and the Movement Disorders Society. Since 2017, he has served on the Movement Disorders Society CME Committee. A focus of Dr. Dashtipour’s research has been on lifestyle modification, such as exercise, in Parkinson’s disease, finding a biomarker for Parkinson’s disease, and developing new medications for managing movement disorders.

Research Keywords & Expertise

Clinical Trials
DBs
Dystonia
Epigenetics
Parkinson's disease

Fingerprints

29%
Parkinson's disease
25%
Clinical Trials
20%
Dystonia
6%
DBs
5%
Epigenetics
5%
Hyperkinetic Movement Disorders

Short Biography

Dr. Khashayar Dashtipour is an Associate Professor of Neurology and Basic Sciences and Director of the Division of Movement Disorders at Loma Linda University. He received his medical degree from Ahvaz Jundishapur University of Medical Sciences and has been in practice for more than 20 years. Dr. Dashtipour has been the principal investigator or sub-investigator of over 40 clinical trials. He is an active member of the Parkinson Study Group, The American Academy of Neurology, and the Movement Disorders Society. Since 2017, he has served on the Movement Disorders Society CME Committee. A focus of Dr. Dashtipour’s research has been on lifestyle modification, such as exercise, in Parkinson’s disease, finding a biomarker for Parkinson’s disease, and developing new medications for managing movement disorders.